Does Rallies show 13F holders for TLPH?

Yes. Rallies tracks hedge fund and 13F ownership data for TLPH, including fund names, share counts, latest tracked quarter, and position changes when available.

Is TLPH research on Rallies investment advice?

No. Rallies provides research, data, and educational context for TLPH. It does not provide personalized investment advice.

TLPH (Talphera, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Talphera, Inc. Common Stock (TLPH) is a publicly traded Healthcare sector company. As of May 21, 2026, TLPH trades at $0.85 with a market cap of $41.38M and a P/E ratio of -2.37. TLPH moved -1.51% today. Year to date, TLPH is -33.01%; over the trailing twelve months it is +59.81%. Its 52-week range spans $0.38 to $1.57. Analyst consensus is strong buy with an average price target of $3.17. Rallies surfaces TLPH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns TLPH stock?

Hedge funds tracked by Rallies that own TLPH include Citadel Advisors, Two Sigma, and Renaissance Technologies. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Talphera, Inc. Common Stock.

TLPH Key Metrics

Key financial metrics for TLPH
Metric	Value
Price	$0.85
Market Cap	$41.38M
P/E Ratio	-2.37
EPS	$-0.34
Dividend Yield	0.00%
52-Week High	$1.57
52-Week Low	$0.38
Volume	1
Avg Volume	0
Revenue (TTM)	$28.00K
Net Income	$-14.29M
Gross Margin	0.00%

Top Hedge Funds Holding TLPH

Citadel Advisors holds 50.45K shares of TLPH, changed +42.97% as of Dec 31, 2024.
Two Sigma holds 20.16K shares of TLPH, changed -48.24% as of Sep 30, 2024.
Renaissance Technologies holds 19.64K shares of TLPH, changed -8.93% as of Dec 31, 2024.

Latest TLPH News

Talphera Advances NEFRO Phase 2 Enrollment, Reports 18% Q1 R&D Spend Rise — May 14, 2026
Talphera Reports Q1 Cash of $21.1M and 50% NEPHRO CRRT Enrollment — May 13, 2026
Talphera Hits 50% Enrollment in NEPHRO-CRRT Trial After 60% Patient Cut — Mar 2, 2026

Recent TLPH Insider Trades

Angotti Vincent J. bought 213.31K (~$125.00K) on Mar 13, 2026.
Angotti Vincent J. bought 105.36K (~$85.59K) on Feb 12, 2026.
Aslam Shakil bought 35.00K (~$28.43K) on Feb 12, 2026.

TLPH Analyst Consensus

3 analysts cover TLPH: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $3.17.

Common questions about TLPH

Who owns TLPH stock?: Hedge funds tracked by Rallies that own TLPH include Citadel Advisors, Two Sigma, and Renaissance Technologies. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Talphera, Inc. Common Stock.
Does Rallies show 13F holders for TLPH?: Yes. Rallies tracks hedge fund and 13F ownership data for TLPH, including fund names, share counts, latest tracked quarter, and position changes when available.
Is TLPH research on Rallies investment advice?: No. Rallies provides research, data, and educational context for TLPH. It does not provide personalized investment advice.